MedTrace Logo

MDs on Botox Utility (MOBILITY)

NCT00535938 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1372

Last updated 2014-09-10

Study results available
· View outcomes & findings →

Summary

The MOBILITY Project is a prospective, non-randomized, observational, multi-centre evaluation of Health Utility via the SF-12® Health Survey Scores and the SF-6D in patients receiving BOTOX® for therapeutic use.

Conditions

  • Blepharospasm
  • Torticollis
  • Strabismus
  • Muscle Spasticity

Interventions

OTHER

botulinum toxin type A

There will be no protocol-mandated intervention with regard to physician treatment choice or management of patient condition once the patient is enrolled in the project.

Sponsors & Collaborators

  • Allergan

    lead INDUSTRY

Principal Investigators

  • Medical Director · Allergan

Eligibility

Min Age
14 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-09-30
Primary Completion
2013-09-30
Completion
2013-09-30

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00535938 on ClinicalTrials.gov